Back
Puma Biotechnology Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
52
PBYI
Puma Biotechnology
Last Price:
4.84
Seasonality Move:
31.31%
Buy
71
REGN
Regeneron Pharmaceuticals
Last Price:
961.54
Seasonality Move:
8.27%
Buy
52
Puma Biotechnology (PBYI)
is a Buy
Is Puma Biotechnology a Buy, Sell or Hold?
- The current Puma Biotechnology [PBYI] share price is $4.75. The Score for PBYI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- PBYI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $969.97. The Score for REGN is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBYI Stock Price Chart
What is Puma Biotechnology's stock price today?
-
The Puma Biotechnology share price today is $4.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBYI is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $969.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PBYI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 39.99 | Sell |
| Chaikin Money Flow: | 209108 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.86 - 5.46) | Sell |
| Bollinger Bands (100): | (4.45 - 5.89) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 67.58 | Buy |
| Chaikin Money Flow: | 325684 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (892.63 - 943.69) | Buy |
| Bollinger Bands (100): | (894.89 - 969.23) | Buy |
PBYI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.9 | Sell |
| 20-day SMA: | 5.06 | Sell |
| 50-day SMA: | 5.3 | Sell |
| 200-day SMA: | 4.23 | Buy |
| 8-day EMA: | 4.86 | Sell |
| 20-day EMA: | 5.02 | Sell |
| 50-day EMA: | 5.17 | Sell |
| 200-day EMA: | 4.52 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 924.06 | Buy |
| 20-day SMA: | 912.11 | Buy |
| 50-day SMA: | 943.31 | Buy |
| 200-day SMA: | 871.2 | Buy |
| 8-day EMA: | 936.25 | Buy |
| 20-day EMA: | 925.41 | Buy |
| 50-day EMA: | 930.24 | Buy |
| 200-day EMA: | 879.64 | Buy |
Puma Biotechnology Earnings Growth & PBYI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.11 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
Puma Biotechnology Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||